Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-03-04 @ 8:46 PM
Study NCT ID:
NCT03711058
Status:
COMPLETED
Last Update Posted:
2025-09-16
First Post:
2018-10-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-15
First Submit QC Date:
None
Study First Post Date:
2018-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-18
Results First Submit QC Date:
None
Results First Post Date:
2023-06-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED